Tapewire

Nasdaq · USD

BBIO

BridgeBio Pharma, Inc.

Export transactions ↓
Tapewire entity
3360
SEC CIK
0001743881
Parsed reports
436

Last 12 months

Inside the activity.

0 purchase rows · 153 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025025
Dec 2025013
Jan 2026014
Feb 2026024
Mar 2026012
Apr 202609
May 2026023
Jun 2026020
Jul 202604
Aug 202607
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 16, 2026 Filed May 19, 2026 20:27 UTC
Kumar NeilDirector · Chief Executive Officer
Tax withholdingCommon Stock 36,236 $66.13 $2,396,286.68
Disclosure

SEC source: 0001470831-26-000472 · wk-form4_1779222471.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 269,430

F2 · shares: Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 71,215 shares of Common Stock underlying the Reporting Person's RSUs.

Read SEC document
May 16, 2026 Filed May 19, 2026 20:27 UTC
Kumar NeilDirector · Chief Executive Officer
Exercise / conversionCommon Stock 6,519 Not disclosed Not disclosed
Disclosure

SEC source: 0001470831-26-000472 · wk-form4_1779222471.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
May 16, 2026 Filed May 19, 2026 20:27 UTC
Kumar NeilDirector · Chief Executive Officer
Exercise / conversionCommon Stock 11,553 Not disclosed Not disclosed
Disclosure

SEC source: 0001470831-26-000472 · wk-form4_1779222471.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299,147

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
May 16, 2026 Filed May 19, 2026 20:27 UTC
Kumar NeilDirector · Chief Executive Officer
Exercise / conversionCommon Stock 19,599 Not disclosed Not disclosed
Disclosure

SEC source: 0001470831-26-000472 · wk-form4_1779222471.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
May 16, 2026 Filed May 19, 2026 20:27 UTC
Kumar NeilDirector · Chief Executive Officer
Exercise / conversionCommon Stock 33,544 Not disclosed Not disclosed
Disclosure

SEC source: 0001470831-26-000472 · wk-form4_1779222471.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $16.75 $0.00
Disclosure

SEC source: 0001470831-26-000470 · wk-form4_1779222325.xml · derivative · entry 7

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,501

Underlying: Common Stock · 10,000 shares

Expires 2033-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.

F5 · derivative.exercise_date: One-third of the shares underlying the option will vest on June 21, 2024; thereafter, one-third of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:25 UTC SaleCommon Stock 200 $69.12 $13,824.00
Disclosure

SEC source: 0001470831-26-000470 · wk-form4_1779222325.xml · nonDerivative · entry 5

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,589

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:25 UTC SaleCommon Stock 1,512 $68.23 $103,164.21
Disclosure

SEC source: 0001470831-26-000470 · wk-form4_1779222325.xml · nonDerivative · entry 4

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,789

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.

F4 · price: Represents the weighted average sale price of the shares sold from $68.10 to $68.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:25 UTC SaleCommon Stock 2,088 $67.53 $141,003.06
Disclosure

SEC source: 0001470831-26-000470 · wk-form4_1779222325.xml · nonDerivative · entry 3

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,301

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.

F3 · price: Represents the weighted average sale price of the shares sold from $67.10 to $68.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:25 UTC SaleCommon Stock 6,200 $66.69 $413,464.36
Disclosure

SEC source: 0001470831-26-000470 · wk-form4_1779222325.xml · nonDerivative · entry 2

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,389

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.

F2 · price: Represents the weighted average sale price of the shares sold from $66.08 to $67.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Read SEC document
May 15, 2026 Filed May 19, 2026 20:25 UTC Exercise / conversionCommon Stock 10,000 $16.75 $167,500.00
Disclosure

SEC source: 0001470831-26-000470 · wk-form4_1779222325.xml · nonDerivative · entry 1

Scott Randal W. · CIK 0001337801 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,589

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on June 27, 2025.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 950 $68.35 $64,930.32
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 12

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,358,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F8 · price: Represents the weighted average sale price of the shares sold from $68.17 to $68.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 5,076 $67.35 $341,845.76
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 11

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,359,397

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F7 · price: Represents the weighted average sale price of the shares sold from $67.10 to $68.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 13,974 $66.65 $931,374.09
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 10

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,364,473

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F6 · price: Represents the weighted average sale price of the shares sold from $66.10 to $67.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 950 $68.35 $64,930.32
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 9

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 555,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F8 · price: Represents the weighted average sale price of the shares sold from $68.17 to $68.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 5,077 $67.35 $341,913.10
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 8

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 556,636

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F7 · price: Represents the weighted average sale price of the shares sold from $67.10 to $68.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 13,973 $66.65 $931,307.44
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 7

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 561,713

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F6 · price: Represents the weighted average sale price of the shares sold from $66.10 to $67.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 449 $69.09 $31,021.90
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 6

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,378,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F5 · price: Represents the weighted average sale price of the shares sold from $69.02 to $69.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 8,334 $68.38 $569,858.09
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,378,896

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F4 · price: Represents the weighted average sale price of the shares sold from $68.02 to $69.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 11,217 $67.49 $757,090.29
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,387,230

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F2 · price: Represents the weighted average sale price of the shares sold from $67.02 to $68.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 450 $69.09 $31,091.00
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 575,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F5 · price: Represents the weighted average sale price of the shares sold from $69.02 to $69.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 8,333 $68.38 $569,789.71
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 576,136

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F4 · price: Represents the weighted average sale price of the shares sold from $68.02 to $69.00 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
May 07, 2026 Filed May 11, 2026 21:15 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 11,217 $67.50 $757,091.42
Disclosure

SEC source: 0001470831-26-000423 · wk-form4_1778534126.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 584,469

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F2 · price: Represents the weighted average sale price of the shares sold from $67.02 to $68.01 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 30, 2026 Filed May 4, 2026 20:22 UTC
Apuli MaricelChief Accounting Officer
SaleCommon Stock 2,000 $71.58 $143,160.00
Disclosure

SEC source: 0001470831-26-000410 · wk-form4_1777926142.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,115

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.

Read SEC document
April 10, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 20,000 $74.60 $1,492,076.00
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 8

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,398,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F10 · price: Represents the weighted average sale price of the shares sold from $74.27 to $75.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 10, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 20,000 $74.60 $1,492,096.00
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 7

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 595,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F9 · price: Represents the weighted average sale price of the shares sold from $74.26 to $75.22 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 7,800 $75.53 $589,123.86
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 6

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,418,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F8 · price: Represents the weighted average sale price of the shares sold from $75.18 to $76.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 5,128 $74.57 $382,379.06
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,426,247

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F7 · price: Represents the weighted average sale price of the shares sold from $74.18 to $75.145 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 7,072 $73.64 $520,801.17
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,431,375

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F6 · price: Represents the weighted average sale price of the shares sold from $73.15 to $74.14 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 7,500 $75.55 $566,661.00
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 615,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F5 · price: Represents the weighted average sale price of the shares sold from $75.22 to $76.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 5,300 $74.60 $395,403.32
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 623,186

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F4 · price: Represents the weighted average sale price of the shares sold from $74.19 to $75.17 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
April 09, 2026 Filed Apr 13, 2026 22:06 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 7,200 $73.64 $530,239.68
Disclosure

SEC source: 0001470831-26-000361 · wk-form4_1776117963.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 628,486

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F2 · price: Represents the weighted average sale price of the shares sold from $73.19 to $74.16 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 18, 2026 Filed Mar 20, 2026 20:32 UTC
Apuli MaricelChief Accounting Officer
GrantCommon Stock 14,170 $0.00 $0.00
Disclosure

SEC source: 0001470831-26-000302 · wk-form4_1774038735.xml · nonDerivative · entry 1

Apuli Maricel · CIK 0002058197 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,115

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2026, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 18, 2026 Filed Mar 20, 2026 20:33 UTC
Trimarchi ThomasPresident and CFO
GrantCommon Stock 59,041 $0.00 $0.00
Disclosure

SEC source: 0001470831-26-000304 · wk-form4_1774038836.xml · nonDerivative · entry 1

Trimarchi Thomas · CIK 0002030813 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 395,626

F1 · kind: Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2026, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F2 · price: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 20:28 UTC
Kumar NeilDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 104,313 $0.00 $0.00
Disclosure

SEC source: 0001470831-26-000296 · wk-form4_1773952086.xml · derivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,313

Underlying: Common Stock · 104,313 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: The RSUs will vest with respect to 1/16th of the underlying shares on May 16, 2026. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

F3 · derivative.expiration_date: The RSUs will vest with respect to 1/16th of the underlying shares on May 16, 2026. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 20:28 UTC
Kumar NeilDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 40,570 $0.00 Strike: $70.94 $0.00
Disclosure

SEC source: 0001470831-26-000296 · wk-form4_1773952086.xml · derivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,570

Underlying: Common Stock · 40,570 shares

Expires 2036-03-16

F1 · derivative.exercise_date: 1/16th of the shares subject to this option vest and become exercisable on May 16, 2026, and thereafter, 1/16th of the shares subject to this option will vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 9,759 $69.23 $675,567.75
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 10

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,438,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F11 · price: Represents the weighted average sale price of the shares sold from $68.82 to $69.55 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 10,241 $68.39 $700,345.12
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 9

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,448,206

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F10 · price: Represents the weighted average sale price of the shares sold from $67.82 to $68.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 10,310 $69.20 $713,448.91
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 8

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 635,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F9 · price: Represents the weighted average sale price of the shares sold from $68.76 to $69.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 13, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 9,690 $68.36 $662,441.35
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 7

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 645,996

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F8 · price: Represents the weighted average sale price of the shares sold from $67.76 to $68.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 300 $70.15 $21,045.00
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 6

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,458,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F5 · price: Represents the weighted average sale price of the shares sold from $70.1 to $70.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 5,815 $69.29 $402,928.91
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 5

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,458,747

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F7 · price: Represents the weighted average sale price of the shares sold from $68.94 to $69.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 13,885 $68.47 $950,686.51
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 4

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 4,464,562

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F6 · price: Represents the weighted average sale price of the shares sold from $67.935 to $68.92 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 300 $70.15 $21,045.00
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 3

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 655,686

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F5 · price: Represents the weighted average sale price of the shares sold from $70.1 to $70.18 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 5,363 $69.32 $371,750.29
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 2

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 655,986

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F4 · price: Represents the weighted average sale price of the shares sold from $68.94 to $69.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 12, 2026 Filed Mar 16, 2026 22:05 UTC
Kumar NeilDirector · Chief Executive Officer
SaleCommon Stock 14,337 $68.48 $981,809.23
Disclosure

SEC source: 0001470831-26-000275 · wk-form4_1773698710.xml · nonDerivative · entry 1

Kumar Neil · CIK 0001742485 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

Disclosed balance after: 661,349

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

F2 · price: Represents the weighted average sale price of the shares sold from $67.935 to $68.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.

Read SEC document
March 10, 2026 Filed Mar 12, 2026 20:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 8,671 $0.00 Strike: $27.36 $0.00
Disclosure

SEC source: 0001470831-26-000260 · wk-form4_1773346534.xml · derivative · entry 4

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,343

Underlying: Common Stock · 8,671 shares

Expires 2034-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer.

Read SEC document
March 10, 2026 Filed Mar 12, 2026 20:15 UTC SaleCommon Stock 8,671 $72.00 $624,312.00
Disclosure

SEC source: 0001470831-26-000260 · wk-form4_1773346534.xml · nonDerivative · entry 2

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,465

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 14, 2025.

Read SEC document
March 10, 2026 Filed Mar 12, 2026 20:15 UTC Exercise / conversionCommon Stock 8,671 $27.36 $237,238.56
Disclosure

SEC source: 0001470831-26-000260 · wk-form4_1773346534.xml · nonDerivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,136

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:57 UTC
Ellis AndreaDirector
Exercise / conversionStock Option (right to buy) · Derivative 64,921 $0.00 Strike: $8.45 $0.00
Disclosure

SEC source: 0001470831-26-000252 · wk-form4_1772834274.xml · derivative · entry 3

Ellis Andrea · CIK 0001877680 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 64,921 shares

Expires 2032-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.